These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. High homocysteine induces betaine depletion. Imbard A; Benoist JF; Esse R; Gupta S; Lebon S; de Vriese AS; de Baulny HO; Kruger W; Schiff M; Blom HJ Biosci Rep; 2015 Apr; 35(4):. PubMed ID: 26182429 [TBL] [Abstract][Full Text] [Related]
64. Liver failure and neurologic disease in a patient with homocystinuria. Snyderman SE Mol Genet Metab; 2006 Mar; 87(3):210-2. PubMed ID: 16359898 [TBL] [Abstract][Full Text] [Related]
65. Evidence of carotid artery wall hypertrophy in homozygous homocystinuria. Megnien JL; Gariepy J; Saudubray JM; Nuoffer JM; Denarie N; Levenson J; Simon A Circulation; 1998 Nov; 98(21):2276-81. PubMed ID: 9826314 [TBL] [Abstract][Full Text] [Related]
66. Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate. Boddie AM; Steen MT; Sullivan KM; Pasquali M; Dembure PP; Coates RJ; Elsas LJ Metabolism; 1998 Feb; 47(2):207-11. PubMed ID: 9472972 [TBL] [Abstract][Full Text] [Related]
67. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Lubec B; Fang-Kircher S; Lubec T; Blom HJ; Boers GH Biochim Biophys Acta; 1996 Apr; 1315(3):159-62. PubMed ID: 8611653 [TBL] [Abstract][Full Text] [Related]
68. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Rothenbacher D; Fischer HG; Hoffmeister A; Hoffmann MM; März W; Bode G; Rosenthal J; Koenig W; Brenner H Atherosclerosis; 2002 May; 162(1):193-200. PubMed ID: 11947914 [TBL] [Abstract][Full Text] [Related]
69. Selections from current literature: homocysteine: a modifiable risk factor for cardiovascular disease. Singh H Fam Pract; 1997 Aug; 14(4):335-9. PubMed ID: 9283857 [No Abstract] [Full Text] [Related]
70. Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type). Heil SG; Hogeveen M; Kluijtmans LA; van Dijken PJ; van de Berg GB; Blom HJ; Morava E J Inherit Metab Dis; 2007 Oct; 30(5):811. PubMed ID: 17768669 [TBL] [Abstract][Full Text] [Related]
71. Putative mechanisms for vascular damage by homocysteine. Bellamy MF; McDowell IF J Inherit Metab Dis; 1997 Jun; 20(2):307-15. PubMed ID: 9211203 [TBL] [Abstract][Full Text] [Related]
72. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. Zavadakova P; Fowler B; Zeman J; Suormala T; Pristoupilová K; Kozich V; Zavad'áková P J Inherit Metab Dis; 2002 Oct; 25(6):461-76. PubMed ID: 12555939 [TBL] [Abstract][Full Text] [Related]
73. [Homocysteine, a risk factor of atherosclerosis]. Ambrosi P; Rolland P; Garçon D Arch Mal Coeur Vaiss; 1996 Dec; 89(12):1667-71. PubMed ID: 9137733 [TBL] [Abstract][Full Text] [Related]
74. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733 [TBL] [Abstract][Full Text] [Related]